SitemapKlarity storyJoin usMedicationServiceAbout us
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
4.9 based on 1,805 reviews
fsaAccept major insurances and cash-pay
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
4.9 based on 1,805 reviews
fsaAccept major insurances and cash-pay
Back

Published: Apr 10, 2026

Share

How to get Wellbutrin fast in Pennsylvania

Share

Written by Klarity Editorial Team

Published: Apr 10, 2026

How to get Wellbutrin fast in Pennsylvania
Table of contents
Share

If you’re struggling with binge eating disorder (BED), you’ve likely wondered whether you can access treatment without the barriers of traditional in-person appointments. The short answer is yes—telehealth has opened doors to effective BED treatment, including prescription medications, for millions of Americans. But navigating the rules around online prescribing can feel overwhelming, especially with recent regulatory changes and state-by-state variations.

This comprehensive guide will walk you through everything you need to know about getting medication for binge eating disorder via telehealth in 2026, including which medications are available, how the legal landscape works, and what to expect from your virtual treatment journey.

Understanding Binge Eating Disorder and Treatment Options

Before diving into telehealth specifics, it’s important to understand what binge eating disorder is and how it’s typically treated.

What Is Binge Eating Disorder?

Binge eating disorder is the most common eating disorder in the United States, affecting approximately 2.8 million Americans. According to DSM-5 criteria, BED is characterized by:

  • Recurrent episodes of eating an unusually large amount of food within a 2-hour period
  • A sense of lack of control during these episodes
  • Binge eating occurring at least once a week for three months
  • Significant distress about the binge eating
  • The absence of regular compensatory behaviors like purging (which would indicate bulimia nervosa)

Unlike other eating disorders, BED isn’t defined by body weight or appearance—people of all sizes can experience this condition.

Traditional Treatment Approaches

Evidence-based treatment for BED typically includes a combination of:

Psychotherapy: Cognitive-behavioral therapy (CBT) and dialectical behavior therapy (DBT) have shown strong effectiveness in reducing binge episodes and addressing underlying emotional triggers.

Nutritional counseling: Working with a registered dietitian can help establish regular eating patterns and reduce the restrict-binge cycle.

Medication: While only one medication (Vyvanse, a controlled stimulant) has FDA approval specifically for BED, several non-controlled medications are commonly used off-label with good results.

Support groups: Peer support can provide accountability and reduce the isolation many people with BED experience.

a woman looking at computer

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

The good news for patients seeking BED treatment is that non-controlled medications can be legally prescribed via telehealth in all 50 states, as long as the provider is licensed in your state and conducts an appropriate evaluation.

Federal Rules: What You Need to Know

At the federal level, the Drug Enforcement Administration (DEA) regulates prescribing of controlled substances through the Ryan Haight Act. However, this law does not apply to non-controlled medications like those commonly used for BED treatment.

The COVID-19 public health emergency led to temporary flexibilities for controlled substance prescribing via telehealth, which have been extended through December 31, 2026. While these extensions primarily affect medications like ADHD stimulants and opioids, they’ve also helped normalize and expand telehealth infrastructure overall.

For the non-controlled medications used in BED treatment—such as Topamax (topiramate) and Wellbutrin (bupropion)—there has never been a federal requirement for an in-person visit before prescribing. This means telehealth providers have consistent, stable authorization to prescribe these medications remotely.

State-by-State Variations

While federal law sets the baseline, individual states can impose additional requirements. The landscape varies considerably:

Most Permissive States: California, New York, Michigan, and Wisconsin have no in-person visit requirement for non-controlled medications. California even allows asynchronous (questionnaire-based) evaluations if they meet the standard of care.

Periodic In-Person Requirements: A few states like Alabama, Georgia, and New Hampshire require patients receiving ongoing telehealth care to have an in-person visit within 12 months. However, this visit can often be completed with any healthcare provider, not necessarily your prescribing telehealth clinician.

No Special Restrictions: The majority of states (including Texas, Florida, Delaware, and South Carolina) allow telehealth prescribing of non-controlled medications as long as the provider conducts an appropriate clinical evaluation—which can be done entirely via video.

Who Can Prescribe BED Medications via Telehealth?

Your telehealth provider can be:

  • Physicians (MD/DO): All states allow physicians to prescribe these medications via telehealth.
  • Nurse Practitioners (NPs): Currently, 34 states plus Washington D.C. grant NPs full practice authority, meaning they can evaluate and prescribe independently. In states like Michigan and Wisconsin, this authority was newly established in 2025. In collaborative states like Texas and Florida, NPs can prescribe under a physician agreement.
  • Physician Assistants (PAs): PAs can prescribe under supervising physician agreements in all states, though the level of autonomy varies.

This means you have access to a wide range of qualified providers through telehealth platforms, increasing appointment availability and reducing wait times.

Non-Controlled Medications for BED: Your Options

While Vyvanse (lisdexamfetamine) is the only FDA-approved medication specifically for binge eating disorder, it’s a Schedule II controlled substance with tighter prescribing restrictions. Most telehealth platforms focus on two well-researched, non-controlled alternatives:

Topamax (Topiramate)

What it is: Originally FDA-approved for seizure disorders and migraine prevention, topiramate has shown promise in reducing binge eating episodes.

How it works: Topiramate affects neurotransmitter activity in the brain, particularly GABA and glutamate, which may help with impulse control and reduce food cravings.

Typical dosing: Treatment usually starts at a low dose (25mg daily) and gradually increases to 100-200mg daily, divided into two doses. The gradual titration helps minimize side effects.

Benefits for BED: Research suggests topiramate can reduce binge frequency and may support modest weight loss, which some patients find motivating.

Important considerations:

  • Pregnancy risk: Topiramate is associated with increased risk of cleft palate and other birth defects. Women of childbearing age should use effective contraception.
  • Side effects: Common side effects include tingling in hands/feet, cognitive changes (‘brain fog’), changes in taste (especially carbonated beverages), and potential kidney stones.
  • Discontinuation: Never stop abruptly—tapering is required to prevent rebound seizures, even if you weren’t taking it for epilepsy.

Wellbutrin (Bupropion)

What it is: FDA-approved for depression and smoking cessation, bupropion has been studied for BED with encouraging results.

How it works: As an atypical antidepressant, bupropion affects dopamine and norepinephrine, which can help regulate mood and potentially reduce binge urges.

Typical dosing: Extended-release formulations (Wellbutrin XL) are usually started at 150mg daily and may be increased to 300mg after several weeks.

Benefits for BED: Some studies show bupropion can reduce binge frequency and may have a modest appetite-suppressing effect for some individuals.

Important considerations:

  • Seizure risk: Bupropion lowers the seizure threshold. It’s contraindicated in anyone with a current or past seizure disorder, or a history of anorexia or bulimia nervosa (these conditions increase seizure risk).
  • Black box warning: Like all antidepressants, bupropion carries a warning about increased suicidal thoughts in people under 25. Close monitoring is essential, especially when starting treatment.
  • Alcohol interaction: Combining bupropion with excessive alcohol increases seizure risk.
  • Blood pressure: Can increase blood pressure, requiring monitoring if you have hypertension.

Off-Label Use: What You Should Know

Both of these medications are prescribed ‘off-label’ for BED, meaning they’re used for a condition other than what the FDA originally approved them for. This is completely legal and extremely common in medicine—in fact, off-label prescribing accounts for approximately 20% of all prescriptions written in the United States.

Clinical research supports the use of both topiramate and bupropion for BED, and reputable telehealth providers will:

  • Explain that the medication is being used off-label
  • Discuss the evidence supporting this use
  • Review alternative treatment options
  • Obtain your informed consent
  • Document all of this in your medical record

The Telehealth Evaluation Process: What to Expect

Getting BED medication through telehealth isn’t—and shouldn’t be—as simple as filling out a questionnaire and receiving a prescription. Legitimate providers follow a thorough evaluation process.

Initial Assessment

Your first appointment will typically last 30-60 minutes and include:

Diagnostic screening: Expect detailed questions about your eating patterns, including:

  • Frequency and characteristics of binge episodes
  • Triggers and emotional context
  • Presence or absence of compensatory behaviors (purging, excessive exercise)
  • Duration of symptoms
  • Impact on your daily functioning

Medical history review: Your provider will ask about:

  • Current and past medical conditions
  • Current medications and supplements
  • Allergies
  • Mental health history, including depression, anxiety, and any prior eating disorders
  • Substance use history
  • Family medical and psychiatric history

Safety screening: Critical questions to determine if you’re a good candidate for telehealth treatment:

  • History of seizures or epilepsy
  • History of anorexia or bulimia
  • Pregnancy status or plans
  • Severe medical instability requiring in-person monitoring
  • Suicidal ideation or other safety concerns

Mental status assessment: The provider will evaluate your current mental state, including mood, thought processes, and judgment.

Identity and Location Verification

Don’t be surprised when your telehealth provider verifies your identity and location. This isn’t distrust—it’s a regulatory requirement in many states to ensure:

  • The provider is licensed in your state
  • You’re receiving care appropriate to your jurisdiction
  • Insurance billing is accurate
  • The provider can prescribe in your location

Treatment Planning

If medication is appropriate, your provider should discuss:

  • Why they’re recommending a specific medication
  • How it works and expected timeline for benefits
  • Potential side effects and how to manage them
  • Starting dose and titration schedule
  • What to do if you experience problems
  • The importance of combining medication with therapy or other support
  • Follow-up schedule

A red flag would be a provider who rushes through this conversation or doesn’t discuss non-medication options.

Safety and Quality: Choosing a Reputable Telehealth Provider

The telehealth boom has brought both innovation and, unfortunately, some questionable practices. Here’s how to identify quality care:

Green Flags (Signs of Quality)

Thorough evaluation: Initial appointments of at least 30 minutes with comprehensive questions

Licensed providers: Clear information about your provider’s credentials and state licensure

Transparency about off-label use: Honest discussion when medications are prescribed for non-FDA-approved indications

Multiple treatment options discussed: Medication isn’t presented as the only solution

Regular follow-up required: Scheduled check-ins, especially when starting new medication

Access to support: Messaging systems or nurse lines for questions between appointments

Privacy compliance: HIPAA-compliant platforms and clear privacy policies

Pharmacy integration: Prescriptions sent to established pharmacies, not shipped from the company itself

Red Flags (Warning Signs)

🚩 Prescription guarantees: Any service promising medication before evaluation

🚩 Minimal assessment: Quick questionnaires without live provider interaction

🚩 No discussion of alternatives: Pushing medication without mentioning therapy or other options

🚩 Controlled substance focus: Legitimate BED telehealth services generally don’t prescribe stimulants online

🚩 Pressure tactics: Urgency to start treatment or subscribe immediately

🚩 Direct medication sales: Company ships pills directly rather than using licensed pharmacies

🚩 No follow-up required: One-and-done prescribing without monitoring

🚩 Unlicensed providers: Inability to verify provider credentials

The 2024 indictment of executives from a telehealth startup for unsafe ADHD medication prescribing serves as a cautionary tale. The company allegedly provided stimulant prescriptions after 30-minute evaluations without adequate safeguards, contributing to the Adderall shortage and putting patients at risk. This enforcement action signals increased scrutiny of telehealth prescribing practices—which ultimately protects patients when done right.

Prescription Monitoring and Medication Access

Do Providers Check Prescription Monitoring Programs?

Most states operate Prescription Drug Monitoring Programs (PDMPs) that track controlled substance prescriptions. While topiramate and bupropion are not controlled substances and therefore don’t trigger mandatory PDMP checks in most states, responsible providers may still review your medication history as good practice.

This review helps ensure:

  • You’re not already on the medication from another provider
  • There are no potentially dangerous drug interactions
  • Your overall medication regimen is safe

This is a safety measure, not an invasion of privacy.

Getting Your Prescription Filled

After your evaluation, your provider will send your prescription electronically to the pharmacy of your choice. You can typically:

  • Use your regular local pharmacy
  • Transfer to a more convenient location
  • Use a mail-order pharmacy (like those offered through insurance plans)
  • Compare prices at different pharmacies if paying cash

Cost considerations: Without insurance, topiramate is relatively affordable (often $10-30/month for generic), while bupropion extended-release can range from $15-100/month depending on formulation. Prices vary significantly by pharmacy, so it’s worth comparing.

Refills and Long-Term Care

Because these are non-controlled medications, providers can typically authorize refills for 6-12 months, depending on state regulations. However, expect regular follow-up appointments, typically:

  • 2-week check-in after starting medication to assess tolerance and side effects
  • Monthly appointments for the first 3-6 months to monitor progress and adjust dosing
  • Every 2-3 months once stable on treatment

Some states (Alabama, Georgia, New Hampshire) require an in-person visit within 12 months for ongoing telehealth care, but this can often be satisfied by seeing any local healthcare provider for a routine check-up.

Who Is NOT a Good Candidate for Telehealth BED Treatment?

Telehealth expands access, but it’s not appropriate for everyone. You may need in-person evaluation if you have:

Contraindications to common medications:

  • History of anorexia or bulimia (contraindication for bupropion due to seizure risk)
  • Seizure disorder or epilepsy (contraindication for bupropion; caution with topiramate)
  • Pregnancy, planning pregnancy, or inadequate contraception (topiramate risk)
  • Severe liver or kidney disease

Medical complexity requiring in-person monitoring:

  • Unstable vital signs or severe metabolic derangement
  • Recent syncope or falls requiring physical examination
  • Concurrent serious medical conditions needing integrated care

Safety concerns:

  • Active suicidal ideation with plan or intent
  • Recent suicide attempt
  • Severe depression unresponsive to outpatient treatment
  • Co-occurring substance use disorder requiring intensive treatment

Need for controlled substances: If your provider determines you need Vyvanse (the FDA-approved stimulant for BED), current telehealth regulations make this more difficult to prescribe remotely, and you may need an in-person evaluation.

Preference for specialized eating disorder programs: Some patients benefit from intensive outpatient programs, partial hospitalization, or residential treatment that addresses BED comprehensively with daily structure and support.

A quality telehealth provider will recognize when you need a higher level of care and provide appropriate referrals.

How Klarity Health Supports Accessible BED Treatment

At Klarity Health, we’ve designed our telehealth platform specifically to address the barriers that keep people from getting eating disorder treatment. Our approach includes:

Provider availability: We maintain a network of board-certified psychiatrists, psychiatric nurse practitioners, and licensed therapists with eating disorder expertise across multiple states, with appointment times often available within 48 hours.

Transparent pricing: Whether you’re using insurance or paying cash, you’ll know the cost upfront—no surprise bills. Our cash-pay rates are competitive and clearly posted, and we accept most major insurance plans.

Integrated care: We don’t just prescribe medication. Our model encourages combining medication management with therapy, and our platform makes it easy to coordinate between providers.

Evidence-based approach: Our providers follow current clinical guidelines and prioritize your safety with thorough evaluations, regular monitoring, and clear communication about risks and benefits.

Flexibility: We understand that binge eating disorder affects busy professionals, parents, students, and people with varying schedules. Evening and weekend appointments, along with secure messaging between visits, make staying engaged with treatment more manageable.

Common Questions About Telehealth BED Treatment

‘Will my insurance cover telehealth for eating disorders?’

Most insurance plans now cover telehealth at the same rate as in-person visits, thanks to policies adopted during the pandemic that have been made permanent or extended. However, coverage varies by plan, so check your specific benefits. Klarity Health can verify your coverage before your first appointment.

‘How long before I see results from medication?’

This varies by individual and medication. Some people notice reduced binge urges within 2-4 weeks, while others may need 6-8 weeks at an optimal dose. It’s important to maintain realistic expectations—medication is a tool that works best alongside therapy and behavioral changes, not a magic solution.

‘Can I stop the medication once my binge eating improves?’

This should always be discussed with your provider. Some people benefit from 6-12 months of treatment while developing new coping strategies, then successfully taper off. Others find that longer-term treatment helps maintain progress. Abrupt discontinuation, especially of topiramate, can be dangerous.

‘What if I live in a rural area with no eating disorder specialists?’

This is exactly where telehealth shines. Geographic barriers that once left people in underserved areas without specialized care are now much less limiting. As long as you have internet access and your provider is licensed in your state, you can access the same quality of care as someone in a major city.

‘Can I switch from in-person to telehealth if I move?’

If you move to a different state, your current telehealth provider may not be able to continue treating you unless they’re licensed in your new state. However, you can transition to a new provider within the same platform who is licensed in your new location, often with warm handoff communication to maintain continuity.

Take the Next Step Toward Recovery

Binge eating disorder is a serious but treatable condition. The expansion of telehealth has made evidence-based treatment—including medication when appropriate—more accessible than ever before. Whether you’re just starting to explore treatment options or you’ve tried other approaches without success, telehealth offers a convenient, private, and effective pathway to care.

Remember that medication is just one component of comprehensive BED treatment. The most successful approaches typically combine:

  • Medication (when clinically appropriate)
  • Individual therapy (especially CBT or DBT)
  • Nutritional counseling
  • Support groups or peer support
  • Mindfulness and stress-management techniques
  • Medical monitoring as needed

Ready to get started? Schedule a comprehensive evaluation with a licensed provider who can assess whether telehealth BED treatment is right for you. At Klarity Health, our team is here to provide personalized, evidence-based care that fits your life—with transparent pricing, flexible scheduling, and providers who genuinely understand eating disorders.

You don’t have to struggle alone, and you don’t have to wait weeks for an appointment or travel hours to see a specialist. Effective help is available right now, from wherever you are.


Research Currency Statement

Verified as of: January 4, 2026

  • DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine.

  • States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.

  • Sources newer than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.

  • Flagged for follow-up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.

Citations

  1. HHS Press Room. (2026, January 2). DEA extends telemedicine prescribing waivers through December 31, 2026. Retrieved from https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

  2. Sheppard Mullin Healthcare Law Blog. (2025, August). Telehealth and in-person visits: Tracking federal and state updates to pandemic-era telehealth exceptions. Retrieved from https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/

  3. Center for Connected Health Policy. (2025, November-December). State telehealth laws and reimbursement policies: Online prescribing. Retrieved from https://www.cchpca.org/topic/online-prescribing/

  4. Health Jobs Nationwide Blog. (2025). State-by-state guide: Expanding roles for PAs and NPs (Updated 2025). Retrieved from https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

  5. National Law Review. (2025). Telehealth and in-person visits: Tracking federal and state updates to pandemic-era telehealth exceptions. Retrieved from https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era

Source:

Get expert care from top-rated providers

Find the right provider for your needs — select your state to find expert care near you.

Related posts

logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402

Join our mailing list for exclusive healthcare updates and tips.

Stay connected to receive the latest about special offers and health tips. By subscribing, you agree to our Terms & Conditions and Privacy Policy.
logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402
If you’re having an emergency or in emotional distress, here are some resources for immediate help: Emergency: Call 911. National Suicide Prevention Lifeline: call or text 988. Crisis Text Line: Text HOME to 741741.
HIPAA
© 2026 Klarity Health, Inc. All rights reserved.